| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
| 1,177 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
| 1,177 | | | Operating Expenses | | Research Development | 10,780 | 9,327 | 13,262 | | Selling General and Administrative | 4,259 | 4,320 | 4,616 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (15,039) | (13,647) | (16,701) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 443 | 678 | 646 | | Earnings Before Interest And Taxes | (14,596) | (12,969) | (16,055) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (14,596) | (12,969) | (16,055) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,596) | (12,969) | (16,055) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (14,596) | (12,969) | (16,055) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,596) | ($12,969) | ($16,055) |
|
1.48% Nasdaq 
Income Statement
